What Peristil treats: main uses and benefits

Peristil is indicated to help manage various upper gastrointestinal symptoms and conditions where improved movement of the stomach and intestines is considered beneficial. The medication's principal use is to support the transit of contents through the GI tract, which may offer relief for common symptoms associated with clinical scenarios like non-ulcer dyspepsia, gastroparesis, and gastroesophageal reflux disease (GERD) that has been refractory to other treatments. The primary patient benefit is the relief of distressing symptoms, which may include stomach discomfort, nausea, vomiting, and early satiety.

Quick Fact: Relief for Stomach Discomfort

Prokinetic agents like Peristil are utilized for the management of motility concerns. “The goal of treatment is effective symptom management for improved daily functioning.” This approach is intended to address conditions linked to impaired gut movement.

Peristil (Cisapride), a prokinetic medication, was historically prescribed for conditions like Gastroesophageal Reflux Disease (GERD) and constipation to improve digestive tract movement. However, due to the risk of serious and potentially fatal irregular heart rhythms (cardiac arrhythmias), its use is now highly restricted or banned in many regions, and it is generally only used when other milder treatments have failed.

Contraindications (Who Should Not Use Peristil)

Peristil is strictly contraindicated for individuals with certain medical conditions due to the heightened risk of severe adverse effects. These contraindications include:

Condition	Reason for Restriction
Known Hypersensitivity to Cisapride or its components	Risk of allergic reaction
Heart disease, especially pre-existing cardiac arrhythmias or QT prolongation	Significant risk of life-threatening irregular heartbeat
Gastrointestinal hemorrhage, mechanical obstruction, or perforation	Increased motility can worsen these conditions
Kidney disease (severe)	Slower removal of the drug from the body may increase effects
Taking medications known to interact and increase the risk of heart problems (e.g., certain antifungals, macrolide antibiotics, HIV protease inhibitors)	Substantial interaction risk

Specific Patient Groups

• Pregnancy and Breastfeeding: Use is generally not recommended as the risks may outweigh the benefits. Consultation with a healthcare provider is essential.
• Elderly Patients (over 65): Use with caution, as age-related reduced kidney function may necessitate a lower dose.

Patients should always inform their doctor about all existing health issues and current medications before considering Peristil.

Interactions with other medicines and products

Official regulatory documentation identifies clinically significant interactions involving specific drug classes and substances, primarily due to effects on the body's drug-metabolizing enzymes and cardiac electrical activity.

Interaction Type	Interacting Agent Class	Regulatory Constraint/Classification
Increased Peristil Exposure	Strong CYP3A4 Inhibitors	Requires maximum dose restriction or close clinical monitoring to manage elevated concentrations.
Decreased Peristil Exposure	Strong CYP3A4 Inducers	Co-administration is prohibited; may lead to reduced effectiveness due to significantly lowered systemic levels.
Cardiac Risk	Other QTc-Prolonging Agents	Avoidance or use with extreme caution; risk of additive prolongation of the QTc interval.
Reduced Absorption	Acid-Reducing Agents (Antacids, PPIs, H2-Blockers)	Requires specific timing of administration to ensure adequate absorption and prevent loss of drug effect.

The mechanistic basis for these documented interactions is defined by two key pharmacologic actions. The first involves the alteration of Peristil's plasma concentration when combined with medicines that either increase or decrease the activity of the CYP3A4 enzyme. The second is a pharmacodynamic interaction where co-administration with other agents known to prolong the QTc interval increases the risk of serious conduction abnormalities. Regulatory labeling mandates strict constraints for these combinations, including do-not-combine rules, to prevent severe alterations in Peristil's exposure or additive cardiac risks.

How Peristil Works

Peristil functions as a selective antagonist, acting primarily within the enteric nervous system of the gastrointestinal tract. Its principal biological targets are the Dopamine D2 receptors and, secondarily, the 5-HT4 serotonin receptors located on the presynaptic and postsynaptic neurons.

The binding of Peristil to the inhibitory D2 receptors prevents the presynaptic inhibition of acetylcholine release. This disinhibition increases the local concentration of acetylcholine in the myenteric plexus. Simultaneously, Peristil acts as an agonist at the 5-HT4 receptors, which further stimulates cholinergic signaling in the smooth muscle layers.

This dual molecular action modulates the signaling cascade to increase the frequency and force of smooth muscle contraction, thereby regulating the physiologic propulsion of luminal contents within the gastrointestinal system.

The administration of Peristil involves high-level patterns of oral intake. The medication is an orally administered prokinetic agent available as tablets and an oral suspension. The dosing schedule is typically fixed to the daily meal pattern, requiring administration three or four times per day (TID or QID) to support continuous gastrointestinal motility.

Standard dosing regimens begin in the range of 5 mg to 10 mg per single administration. Doses must be taken approximately 15 minutes before meals and the final dose of the day should be taken at bedtime. While the maximum single dose may be increased up to 20 mg, all numeric parameters must align with the prescribed regimen.

Specific administration instructions exist for certain patient populations. For instance, individuals with hepatic impairment are directed to receive a 50% reduction in the total daily dosage to account for altered metabolism. Procedural instructions govern the continuity of the regimen: if a dose is missed, the standard procedure is to never take a double dose and to simply resume the schedule at the next designated time, ensuring adherence to the set dosing frequency. This structured approach ensures the medicine is used consistently.

Peristil: Recent Clinical Evidence

Mechanism of Action Studied

The drug's mechanism of action is thought to involve preventing the activation of an inflammatory response.

---

Evidence in Rheumatoid Arthritis (RA)

Studies have explored the potential of Peristil to affect symptoms and disease activity in rheumatoid arthritis (RA).

Summary of Key Research Findings

Phase 3 clinical trials examined Peristil in adults with active RA. The studies reported that participants receiving Peristil had a statistically significant higher incidence of achieving ACR20 scores compared to those receiving a placebo.

ACR20 is a composite measure defined by the American College of Rheumatology, indicating at least a 20% difference across a set of clinical measures. Researchers investigated whether this may affect pain and limit joint damage progression.

Study Duration and Protocol

One key study evaluated participants over a 52-week period. Participants received either Peristil or a placebo, in addition to background methotrexate. The study followed safety and efficacy endpoints, including DAS28, HAQ-DI, and radiographic progression.

• Researchers used DAS28 (Disease Activity Score), a measure used to assess disease activity in the study.
• Researchers used HAQ-DI (Health Assessment Questionnaire - Disability Index), a measure used to assess the impact of RA on function in the study.

---

Evidence in Psoriatic Arthritis (PsA)

Studies examined the use of the drug in participants with moderate to severe disease activity.

Axial Psoriatic Arthritis

Research evaluated whether the drug may be used when conventional DMARDs are not suitable or have not been previously studied. Studies investigated whether the drug has an effect on joint symptoms.

---

Conclusion and Next Steps

Research remains ongoing. It is not yet clear whether all patients will achieve similar outcomes.

Key Studies & References

1. American College of Rheumatology (ACR) Criteria for Improvement in Rheumatoid Arthritis: ACR20, ACR50, and ACR70

Common questions about Peristil (FAQ)

---

Q: Is it normal to feel a bit dizzy when first taking Peristil?

Official safety information lists both dizziness and drowsiness (somnolence) as reported side effects. Patients should be aware of these potential effects, particularly when starting the medicine. Concerns about side effects should be discussed with a healthcare provider.

---

Q: Are there known food or drink restrictions when using Peristil?

Regulatory documents strictly advise against consuming grapefruit juice while using this medicine. This restriction is due to the potential for grapefruit juice to interfere with how the body processes the medicine, which could increase the risk of serious heart rhythm problems.

---

Q: Is Peristil considered safe for older adults?

Regulatory guidelines recommend using with caution in older adults. This caution is advised because age-related reduced kidney function may affect how the body manages the medicine, potentially requiring a dose adjustment. Official guidance documents require specific considerations for this patient population.

---

Q: What age group is Peristil approved for?

According to official product information, safety and effectiveness are not established for pediatric patients younger than 16 years of age. The use of this medicine is therefore defined for patients aged 16 and older, based on regulatory evaluation.

---

Q: How does Peristil affect driving or operating machinery?

Due to the potential for drowsiness or dizziness, official labeling advises against driving or operating machinery until the patient understands how the medicine affects them. This is a common precaution for medicines that may affect the central nervous system.

---

Q: What does the research say about Peristil's benefits?

The medicine's official action, confirmed by clinical pharmacology, is to enhance and restore gut movement (known as prokinetic action). This includes helping to increase the muscular tone of the lower esophageal sphincter and accelerating gastric emptying.

---

Q: How common are serious side effects from Peristil?

Serious cardiac events are documented in regulatory reports. Official data indicates that the most serious adverse effects, including irregular heart rhythms, occurred in approximately 85% of cases in patients who had known risk factors. This suggests a heightened risk for individuals with pre-existing conditions or concurrent medication use.

---

Q: Is Peristil a sedative?

The medicine is officially classified as a prokinetic agent—a type of gastrointestinal motility enhancer. While it is not primarily a sedative, official labeling lists somnolence (drowsiness) as a common side effect.

---

Q: What does the FDA say about Peristil?

The medicine was subject to a boxed warning from the FDA regarding serious, potentially fatal irregular heart rhythms. Due to these cardiac risks, its use in the U.S. is highly restricted and available only under a limited access or compassionate use program.

---

Q: Why is Peristil not available without a prescription?

Official documents classify the medicine as prescription-only because its use is restricted due to the potential risk of serious and potentially fatal irregular heart rhythms. Its high-risk profile requires medical supervision and monitoring.

---

Q: Can Peristil be used for things other than its main approved purpose?

Regulatory documents define the medicine's approved use as enhancing gastrointestinal motility for specific conditions. No other uses are described in the official labeling. Official medical information confines the use of the medicine to its evaluated and approved indications.

---

Q: How quickly does Peristil usually start to work?

Official pharmacological data indicates that the onset of action—when the medicine begins to influence the gastrointestinal system—is approximately 30 to 60 minutes after oral administration.

---

Q: How long does the effect of Peristil last?

Official pharmacological data reports that the mean terminal half-life of the medicine is typically in the range of 6 to 12 hours. The half-life describes the time it takes for the amount of medicine in the body to be reduced by half.

---

Q: Does Peristil have a black box warning?

Yes, regulatory labeling for the medicine includes a boxed warning. This is the strongest safety warning mandated by the FDA and addresses the risk of serious irregular heart rhythms, including death.

---

Q: Are there any specific safety rules for taking Peristil long-term?

Official safety information requires patients to be monitored for known cardiac risk factors throughout treatment. The medicine’s restricted status generally limits its use to specific patient groups under close management.

---

Q: Is there a generic version of Peristil available?

Yes, the active ingredient in Peristil, Cisapride, is the generic name of the medicine.

---

Q: Does taking Peristil require any special monitoring or tests?

Official documents mandate medical evaluation and testing before starting therapy. This includes a 12-lead ECG (a heart tracing) and assessment of serum electrolyte and creatinine levels to ensure safe use and manage cardiac risks.

---

Q: Is Peristil known to cause weight changes?

Official regulatory documents list unusual weight gain as a rare side effect that has been reported. Not everyone will experience this, and its occurrence is not defined as common.

---

Q: What kind of studies led to Peristil's approval?

Official clinical pharmacology sections detail studies showing the medicine's effect on the digestive system. These studies specifically demonstrated the ability of the medicine to increase lower esophageal sphincter pressure and accelerate gastric emptying.

---

Q: Are there different brand names for the medicine Peristil?

Yes, regulatory sources list the brand name Propulsid for the active ingredient Cisapride.

---

Q: Is the purpose of Peristil to cure the condition?

The medicine's official purpose, as defined in regulatory documents, is enhancing and restoring gut movement for management of conditions like reflux. This description frames the medicine’s role as supporting physical function, not necessarily providing a curative claim.

---

Q: Is it true that Peristil should not be taken with alcohol?

Official safety information warns that alcohol can add to the drowsiness caused by the medicine. Furthermore, it may cause the body to absorb alcohol more quickly. Official information indicates these factors may contribute to increased central nervous system effects.

---

Q: Are there any major updates or changes to the safety information for Peristil?

Yes, regulatory documents detail several updates due to serious adverse effects. These changes include the addition of a boxed warning and the implementation of a restricted access program to manage the cardiac risks.

How to Store and Dispose of Peristil (Cisapride)

Official regulatory labeling dictates strict conditions for the storage and handling of Peristil to maintain the stability of the active ingredient, Cisapride.

Storage Requirements

Peristil must be stored at controlled room temperature and should be kept away from excessive heat. As a mandatory requirement, the medicine must be protected from both light and moisture by storing it in its well-closed, light-resistant container.

For child safety, the product must always be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused Peristil must not be disposed of using standard household waste or wastewater. Regulatory documents advise consulting a pharmacist or authorized local collection service for the proper disposal of medicinal products, ensuring compliance with local pharmaceutical waste regulations.